{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"364"},{"groupId":"OG001","value":"179"}]}]}],"denomUnitsSelected":"Participants","denoms":[{"counts":[{"groupId":"OG000","value":"380"},{"groupId":"OG001","value":"189"}],"units":"Participants"}],"description":"Any untoward medical occurrence in a patient or clinical investigation participants administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.","groups":[{"description":"Tremelimumab 10mg/kg","id":"OG000","title":"TREMELIMUMAB"},{"description":"Placebo.","id":"OG001","title":"PLACEBO"}],"paramType":"NUMBER","populationDescription":"Safety population","reportingStatus":"POSTED","timeFrame":"Day 1- 90 days post dose","title":"Number of Participants Reporting Any Adverse Event","type":"SECONDARY","typeUnitsAnalyzed":"Participants","unitOfMeasure":"Participants"}